Cancer clinical trials in the region Nouvelle-Aquitaine
195 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Prostate cancer
#NCT05116475
Adenocarcinoma
Metastatic Hormone-sensitive
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Oncologie RadioThérapie 37 (Chambray-lès-Tours), Hôpital Privé des Peupliers - Ramsay Santé (Paris)
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Phase 3
Breast cancer
#NCT05774951
HER2 Negative
HR Positive
Localized
Surgery
Hormone therapy
Centre Hospitalier d'Avignon (Avignon), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier d'Argenteuil (Argenteuil), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Groupe Hospitalier Saint André (Bordeaux) (and 20 more...)
AstraZeneca
Phase 3
Prostate cancer
#NCT04916613
Metastatic Hormone-sensitive
Systemic Treatment-Naive
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Bergonié (Bordeaux), CHP Brest - Pasteur Vivalto Santé (Brest) (and 35 more...)
UNICANCER
Phase 3
Lung cancer
#NCT04603807
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Bergonié (Bordeaux), Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Hôpital Robert Schuman - UNEOS (Vantoux)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT04158362
HER2 Negative
HR Positive
Metastatic
Systemic Treatment-Naive
Chemotherapy
Hormone therapy
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Eugene Marquis (Rennes)
UNICANCER
Phase 3
Breast cancer
#NCT03820830
HER2 Negative
HR Positive
Localized
Surgery
Radiotherapy
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Antoine Lacassagne (Nice) (and 7 more...)
ETOP IBCSG Partners Foundation
Phase 3
Lung cancer
#NCT03774732
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Locally Advanced
Metastatic
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
EGFR
ALK
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut Sainte Catherine (Avignon), Institut Bergonié (Bordeaux), Centre François Baclesse (Caen ), Centre Hospitalier du docteur Jean Eric Techer (Calais) (and 26 more...)
UNICANCER
Phase 3
Lymphoma
#NCT06191744
B cell lymphoma
Follicular lymphoma
CD20
Systemic Treatment-Naive
None
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital Saint Louis AP-HP (Paris), Centre Hospitalier du Mans (Le Mans), CHU Caen Normandie (Caen), Centre Hospitalier d'Avignon (Avignon) (and 2 more...)
Genmab
Phase 3
Lymphoma
#NCT06091254
B cell lymphoma
Follicular lymphoma
CD20
Systemic Treatment-Naive
None
Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier d'Argenteuil (Argenteuil), Centre Hospitalier Régional Universitaire de Tours (Tours), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 2 more...)
Regeneron Pharmaceuticals
Phase 3
Breast cancer
#NCT05646862
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
Targeted therapy
Hormone therapy
Centre Hospitalier de la Côte Basque (Bayonne), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre Léon Bérard (Lyon), Institut du cancer de Montpellier (Montpellier), IUCT Oncopôle (Toulouse) (and 2 more...)
Hoffmann-La Roche